DRUG ALERTS & UPDATES
Providers: We’re here to help
Our partnership with our members’ healthcare providers is essential to ensure that we continue to deliver best in class pharmacy care to our members. We work closely with providers to deliver appropriate care management designed to lower net costs while maximizing health outcomes. The overall result: happier and healthier patients!
Member Services: 1.877.241.7123 / TDD 1.888.907.0020
Pharmacy Help Desk Assistance: 1.888.907.0050
Prior Auths/DUR: 1.888.723.6001
On June 28, 2016, FDA approved Gilead’s new drug, Epclusa, to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin.read more